home / stock / jazz / jazz quote
Last: | $108.99 |
---|---|
Change Percent: | 0.33% |
Open: | $110.13 |
Close: | $108.99 |
High: | $110.5 |
Low: | $108.205 |
Volume: | 574,028 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$108.99 | $110.13 | $108.99 | $110.5 | $108.205 | 574,028 | 05-17-2024 |
$110.49 | $109.37 | $110.49 | $110.78 | $108.9 | 675,570 | 05-16-2024 |
$109.74 | $112.37 | $109.74 | $113.055 | $109.29 | 812,898 | 05-15-2024 |
$112.01 | $113.96 | $112.01 | $113.96 | $110.68 | 451,209 | 05-14-2024 |
$113.17 | $110.46 | $113.17 | $113.51 | $110.38 | 655,755 | 05-13-2024 |
$109.63 | $113.15 | $109.63 | $113.84 | $109.32 | 564,155 | 05-10-2024 |
$113.12 | $110.97 | $113.12 | $113.18 | $109.8 | 812,109 | 05-09-2024 |
$110.7 | $111.94 | $110.7 | $112.47 | $110.045 | 771,168 | 05-08-2024 |
$111.21 | $109.5 | $111.21 | $111.58 | $108.6 | 841,956 | 05-07-2024 |
$109.85 | $110.14 | $109.85 | $111.255 | $109.54 | 571,215 | 05-06-2024 |
$110.01 | $110.14 | $110.01 | $111.55 | $108.58 | 693,769 | 05-03-2024 |
$109.29 | $105.14 | $109.29 | $113.36 | $103.01 | 1,061,749 | 05-02-2024 |
$110.31 | $110.13 | $110.31 | $112.19 | $110.0122 | 797,965 | 05-01-2024 |
$110.75 | $110.96 | $110.75 | $112.15 | $110.08 | 613,990 | 04-30-2024 |
$111.22 | $109.9 | $111.22 | $112.17 | $109.5 | 781,433 | 04-29-2024 |
$109.46 | $107 | $109.46 | $110.8214 | $106.73 | 480,575 | 04-26-2024 |
$107.43 | $108.25 | $107.43 | $109.05 | $107.22 | 424,856 | 04-25-2024 |
$108.32 | $108.66 | $108.32 | $109.39 | $107.6 | 401,278 | 04-24-2024 |
$109.67 | $109.72 | $109.67 | $110.44 | $108.9 | 376,838 | 04-23-2024 |
$108.83 | $110.33 | $108.83 | $110.465 | $108.405 | 514,011 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Jazz Pharmaceuticals plc Company Name:
JAZZ Stock Symbol:
NASDAQ Market:
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA)...
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. This gr...